147 related articles for article (PubMed ID: 35865159)
1. Prediction of Sentinel Lymph Node Biopsy Status in Breast Cancers with PET/CT Negative Axilla.
Chinnappan S; Chandra P; Kumar S; Sridev MB; Jain D; Chandran G; Nath S
World J Nucl Med; 2022 Jun; 21(2):120-126. PubMed ID: 35865159
[No Abstract] [Full Text] [Related]
2. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
[TBL] [Abstract][Full Text] [Related]
3. Prediction of macrometastasis in axillary lymph nodes of patients with invasive breast cancer and the utility of the SUV lymph node/tumor ratio using FDG-PET/CT.
Futamura M; Asano T; Kobayashi K; Morimitsu K; Nawa M; Kanematsu M; Morikawa A; Mori R; Yoshida K
World J Surg Oncol; 2015 Feb; 13():49. PubMed ID: 25885028
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
Cooper KL; Meng Y; Harnan S; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E
Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372
[TBL] [Abstract][Full Text] [Related]
7. Value of frozen section and primary tumor factors in determining sentinel lymph node spread in early breast carcinoma.
Jaka RC; Zaveri SS; Somashekhar SP; Sureshchandra ; Parameswaran RV
Indian J Surg Oncol; 2010 Jan; 1(1):27-36. PubMed ID: 22930615
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
[TBL] [Abstract][Full Text] [Related]
9. Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer.
Li C; Tian Y; Shen Y; Wen B; He Y
AJR Am J Roentgenol; 2021 Dec; 217(6):1433-1443. PubMed ID: 33978465
[No Abstract] [Full Text] [Related]
10. Role of primary breast cancer characteristics in predicting positive sentinel lymph node biopsy results: a multivariate analysis.
Chen M; Palleschi S; Khoynezhad A; Gecelter G; Marini CP; Simms HH
Arch Surg; 2002 May; 137(5):606-9; discussion 609-10. PubMed ID: 11982477
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
[TBL] [Abstract][Full Text] [Related]
12. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY
J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884
[TBL] [Abstract][Full Text] [Related]
13. A comparative analysis of axillary nodal burden in ultrasound/biopsy positive axilla vs ultrasound negative sentinel lymph node biopsy positive axilla.
Tandon M; Ball W; Kirby R; Soumian S; Narayanan S
Breast Dis; 2019; 38(3-4):93-96. PubMed ID: 30909179
[TBL] [Abstract][Full Text] [Related]
14. Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (Pilot study).
Eldweny H; Alkhaldy K; Alsaleh N; Abdulsamad M; Abbas A; Hamad A; Mounib S; Essam T; Kukawski P; Bobin JY; Oteifa M; Amanguono H; Abulhoda F; Usmani S; Elbasmy A
J Egypt Natl Canc Inst; 2012 Mar; 24(1):23-30. PubMed ID: 23587229
[TBL] [Abstract][Full Text] [Related]
15. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
Nakajima N; Kataoka M; Sugawara Y; Ochi T; Kiyoto S; Ohsumi S; Mochizuki T
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):738-46. PubMed ID: 24064322
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Probability of Non-sentinel Lymph Node Metastasis in Breast Cancer Patients with Sentinel Lymph Node Metastasis using Two Different Methods.
Başoğlu İ; Çelik MF; Dural AC; Ünsal MG; Akarsu C; Baytekin HF; Kapan S; Alış H
J Breast Health; 2015 Oct; 11(4):172-179. PubMed ID: 28331717
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Pathological Factors Affecting the Sentinel Lymph Node Metastasis in Patients with Breast Cancer.
Karahallı Ö; Acar T; Atahan MK; Acar N; Hacıyanlı M; Kamer KE
Indian J Surg; 2017 Oct; 79(5):418-422. PubMed ID: 29089701
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of primary tumor parameters using
Yoo J; Kim BS; Yoon HJ
Ann Nucl Med; 2018 Nov; 32(9):642-648. PubMed ID: 30094546
[TBL] [Abstract][Full Text] [Related]
19. Artificial neural network models to predict nodal status in clinically node-negative breast cancer.
Dihge L; Ohlsson M; Edén P; Bendahl PO; Rydén L
BMC Cancer; 2019 Jun; 19(1):610. PubMed ID: 31226956
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the negative predictive value of positron emission tomography/computed tomography for axillary lymph node staging in breast cancer patients.
Kim J; Cho H; Gwak G; Yang K; Kim JY; Shin YJ; Seo YY; Park I
Asian J Surg; 2020 Jan; 43(1):193-200. PubMed ID: 30914155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
